TC BioPharm signs LoI to acquire ophthalmic pharma company
TC BioPharm (TCBP) has signed a non-binding letter of intent (LoI) to acquire an ophthalmic pharmaceutical company focused on commercialising…
All articles by
-
-
Trimtech closes seed fund round to advance CNS therapeutics pipeline
Trimtech Therapeutics has closed a seed funding round of $31m (£25m) to advance its pipeline of the central nervous system…
-
FDA approves ARS’ neffy 1mg for paediatric anaphylaxis
The US Food and Drug Administration (FDA) has approved ARS Pharmaceuticals' neffy 1mg (epinephrine nasal spray) for treating type one…
-
Indonesia approves Antengene’s Xpovio NDA for multiple indications
Antengene’s new drug application (NDA) for Xpovio (selinexor) has gained approval from the Indonesia National Agency of Drug and Food…
-
WuXi Biologics introduces E coli expression system
WuXi Biologics has launched the E coli expression system, EffiX, designed to enhance the production of recombinant proteins and plasmid DNA…
-
FDA approves BeiGene’s Tevimbra plus chemo for oesophageal cancer
The US Food and Drug Administration (FDA) has approved BeiGene’s Tevimbra (tislelizumab-jsgr) along with platinum-containing chemotherapy as first-line treatment for…
-
Callio raises $187m for proof-of-concept for dual-payload ADC
Callio Therapeutics has raised $187m in a Series A financing round to achieve clinical proof-of-concept for its human epidermal growth…
-
EU set to approve AstraZeneca’s Imfinzi-chemo combo for NSCLC
AstraZeneca's Imfinzi (durvalumab) plus chemotherapy combo has received the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP)…
-
Nuvation Bio secures $250m for taletrectinib commercialisation
Nuvation Bio has secured $250m in non-dilutive financing from Sagard Healthcare Partners to fully fund the commercialisation of taletrectinib in…
-
EC approves Bavarian Nordic’s chikungunya vaccine marketing
The European Commission (EC) has authorised the marketing of Bavarian Nordic's Vimkunya - the first chikungunya vaccine approved in Europe…